⌘K

Login Start Free

Home/Filings/4/0001209191-18-000376

4//SEC Filing

MCGRATH JOHN 4

Accession 0001209191-18-000376

CIK 0001604464other

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 7:14 PM ET

Size

4.7 KB

Accession

0001209191-18-000376

Insider Transaction Report

Form 4

Period: 2017-12-29

Atara Biotherapeutics, Inc.ATRA

Chief Financial Officer

Transactions

Sale
Common Stock
2017-12-29$20.00/sh−32,000$640,000→ 96,654 total

Footnotes (1)

[F1]Transaction pursuant to Rule 10b5-1 Plan adopted July 6, 2016.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001205442

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 7:14 PM ET
Size: 4.7 KB

View on SEC.gov